Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Subscription fees cover clinical access, not medication: Month-to-Month Plan: $99, billed every 28 days 3-Month Plan: $177 total, billed every 3 months (works out to $59/month) 6-Month Plan: $354 total, billed every 6 months (works out to $59/month) Annual Plan: $708 total, billed once per year (works out to $59/month) Medication costs, separate from the subscription, without insurance: Wegovy pill and Foundayo: around $149/month Wegovy pen and Ozempic: around $199/month Zepbound KwikPen and vial: around $299/month, with higher doses up to $698/month Standard Zepbound injector pen: listed separately, starting near $1,086/month Format and dose make a real difference here - don't assume a single "starting at" figure applies across every Zepbound option
Do not use different brands of semaglutide at the same time
In vitro and in vivo studies have demonstrated the action of GLP1-RAs through the suppression of endothelin-1 at the vascular level by decreasing the phosphorylation of nuclear factor kappa B (NF-B) in the presence of elevated glucose concentrations, as occurs in patients with type 2 diabetes mellitus (DM2)
GLP-1s on track to take drug sales throne from PD-1 inhibitors in 2024: analyst
